Literature DB >> 14504167

Circulating S100B is increased after bilateral femur fracture without brain injury in the rat.

L E Pelinka1, L Szalay, M Jafarmadar, R Schmidhammer, H Redl, S Bahrami.   

Abstract

BACKGROUND: S100B is an acknowledged marker of brain damage. However, trauma without brain damage also causes an increase in S100B. S100B concentrations are highest in multiple trauma patients with long bone fractures. Clinically, extensive long bone fractures are associated with haemorrhagic shock and haemorrhagic shock per se is associated with increased S100B. The aim of our experimental study was to verify the S100B increase in long bone fracture without haemorrhagic shock.
METHODS: and results. Bilateral femur fracture was carried out in 10 anaesthetized rats. Blood samples were drawn for immuno-luminometrical S100B measurement 5, 15, 30, 120, and 240 min after fracture. Mean arterial pressure (MAP), heart rate, and body temperature were monitored continuously. S100B increased after bilateral femur fracture and reached a peak 30-120 min after fracture (P<0.001). MAP remained at a level which is not associated with shock in rats. Heart rate and body temperature remained unchanged. Autopsy verified open bilateral femur fracture surrounded only by small zones of clotted blood.
CONCLUSIONS: S100B is increased in bilateral femur fracture without haemorrhagic shock in rats. This finding suggests that bone marrow is a potential extracerebral source of S100B.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504167     DOI: 10.1093/bja/aeg225

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  15 in total

1.  S100B protein may detect brain death development after severe traumatic brain injury.

Authors:  Juan J Egea-Guerrero; Francisco Murillo-Cabezas; Elena Gordillo-Escobar; Ana Rodríguez-Rodríguez; Judy Enamorado-Enamorado; Jaume Revuelto-Rey; María Pacheco-Sánchez; Antonio León-Justel; Jose M Domínguez-Roldán; Angel Vilches-Arenas
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

2.  Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.

Authors:  Ming C Liu; Linnet Akinyi; Dancia Scharf; Jixiang Mo; Stephen F Larner; Uwe Muller; Monika W Oli; Wenrong Zheng; Firas Kobeissy; Linda Papa; Xi-Chun Lu; Jitendra R Dave; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Eur J Neurosci       Date:  2010-02       Impact factor: 3.386

Review 3.  Clinical applications of biomarkers in pediatric traumatic brain injury.

Authors:  Simon J I Sandler; Anthony A Figaji; P David Adelson
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

4.  The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity.

Authors:  Andrea Kleindienst; Christian Schmidt; Hans Parsch; Irene Emtmann; Yu Xu; Michael Buchfelder
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-08

Review 5.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

6.  Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game.

Authors:  B-M Stålnacke; A Ohlsson; Y Tegner; P Sojka
Journal:  Br J Sports Med       Date:  2006-04       Impact factor: 13.800

7.  The Influence of Bone Cement Implantation in Primary Hip Arthroplasty on S100B Protein Serum Concentration and Patients' Cognitive Functions as Markers of Brain Damage.

Authors:  Dariusz Tomaszewski; Zbigniew Rybicki; Marcin Możański
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-12       Impact factor: 3.693

8.  The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury.

Authors:  Kevin J Anderson; Stephen W Scheff; Kelly M Miller; Kelly N Roberts; Lesley K Gilmer; Cui Yang; Gerry Shaw
Journal:  J Neurotrauma       Date:  2008-09       Impact factor: 5.269

9.  Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.

Authors:  Brian J Blyth; Arash Farhavar; Christopher Gee; Brendan Hawthorn; Hua He; Akshata Nayak; Veit Stöcklein; Jeffrey J Bazarian
Journal:  J Neurotrauma       Date:  2009-09       Impact factor: 5.269

10.  S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.

Authors:  Akash Goyal; Michelle D Failla; Christian Niyonkuru; Krutika Amin; Anthony Fabio; Rachel P Berger; Amy K Wagner
Journal:  J Neurotrauma       Date:  2013-06-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.